Functional and morphological cardiac changes in myeloproliferative disorders (clinical study)
Authors:
- Gurhan KadikoyluGKGurhan Kadikoylu
- Alper OnbasiliAOAlper Onbasili
- Tarkan TektenTTTarkan Tekten
- Sabri BarutcaSBSabri Barutca
- Zahit BolamanZBZahit Bolaman
- 1 November 2004
- journal article
- Published by Elsevier in International Journal of Cardiology
- Vol. 97 (2) , 213-220
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Myeloproliferative disorders: complications, survival and causes of deathAnnals of Hematology, 2000
- Pulmonary hypertension in patients with myelofibrosis secondary to myeloproliferative diseasesAmerican Journal of Hematology, 1999
- Thrombotic and hemorrhagic complications in chronic myeloproliferative disordersBiomedicine & Pharmacotherapy, 1996
- Polycythemia Vera: The Natural History of 1213 Patients Followed for 20 YearsAnnals of Internal Medicine, 1995
- Pulmonary hypertension in polycythemia veraAmerican Journal of Hematology, 1994
- Coronary vasospasm, multiple coronary thrombosis, unstable angina and essential thrombocytosisInternational Journal of Cardiology, 1993
- Vascular complications of essential thrombocythaemia: a link to cardiovascular risk factorsBritish Journal of Haematology, 1993
- Incidence and clinical risk factors for bleeding and thrombotic complications in myeloproliferative disordersAnnals of Hematology, 1991
- Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia.Journal of Clinical Oncology, 1990
- Thrombohaemorrhagic complications in 101 cases of myeloproliferative disorders: Relationship to platelet number and functionEuropean Journal of Cancer and Clinical Oncology, 1983